
    
      All participants will receive a single dose of their assigned vaccination at Visit 1 (Day 0)
      and undergo immunogenicity assessment at Day 28 post-vaccination. Safety will be assessed
      from day of vaccination and up to 6 months post-vaccination.
    
  